Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Masco (MAS)
NYSEIndustrialsConstruction MaterialsSnapshot 2026-11-05
$83.83-3.44%
Close 2026-11-05 · 1-day change
NYSEIndustrialsConstruction MaterialsSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.65 → 4.70 EPS · FY ending Dec 31, 2027 · 14 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 14 to 14; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for MAS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain EPS guidance at or above $4.10 for 2026 | Masco keeps its EPS guidance steady near $4.10 for 2026. | Under Pressure | EPS guidance falls below $4.10 for FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
MAS is a financially strong industrial business with a value-oriented setup, rather than a clear-cut durable compounder. Its long-term thesis is intact, with recent performance holding in the upper half of its industry, though earnings quality is fragile and confidence in the evidence is medium.
The valuation is described as cheap versus peers, and the valuation measure recently fell. The evidence labels current expectations as justified, with low concern that the setup is especially vulnerable to weak execution and turbulence; it does not indicate that the market assumes strong future growth.
Near-term results have been strong: third-quarter net sales rose 4 percent excluding divestitures and currency effects, and adjusted operating margin increased from a year earlier. Management has delivered on margin improvement and capital allocation, but the sector backdrop is a headwind, and recent history of a deep miss plus industry peer misses warrant attention.
Over the next one to three years, a key test is whether MAS can sustain its recent guidance and execution. Reversing its recent guidance increase would damage credibility, while continued earnings strength and higher guidance from industrial peers could support the sector backdrop; peer misses or lower guidance could weaken it.
The multi-year view is intact, with recent operating progress and a cheap-versus-peers valuation balanced by fragile earnings quality and sector risk. The central question is whether execution and guidance remain consistent as industrial conditions evolve. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Leadership changes support management's transition goals. |
| Intact |
| significant operational disruption or negative leadership news impacting results |
Qualitative: No operational disruption Three consecutive quarterly earnings beats and maintained 2026 EPS guidance indicate stable operations despite leadership changes. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve at least 3% revenue growth annually | A primary condition in Masco's published investment case. The stated target is >=3% YoY revenue growth. | Broken | YoY revenue growth falls below 3% over next 4 quarters | Revenue growth: 2.56% FY2026-Q3; GAAP. Published target: >=3% YoY revenue growth. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Oct 28, 20262.556077 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain valuation discount to peer median PE | A supporting condition in Masco's published investment case. The stated target is PE below 24. | Intact | PE rises above peer median of 24 without earnings growth justification | P/E (TTM): 17.87x As of 2026-11-05; trailing twelve months. The target timing and basis require a separate assessment. Nov 5, 202617.8742 ratio · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.71 → $4.70 · observed estimates
$8.01B → $7.87B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $4.71 | $8,012,605,960 | 21 / 19 |
| 2026-07-25 | $4.71 | $8,012,605,960 | 21 / 19 |
| 2026-07-26 | $4.71 | $8,012,605,960 | 21 / 19 |
| 2026-07-27 | $4.71 | $8,012,605,960 | 21 / 19 |
| 2026-07-28 | $4.71 | $8,019,845,559 | 13 / 14 |
| 2026-07-29 | $4.71 | $8,012,605,960 | 21 / 19 |
| 2026-07-30 | $4.72 | $8,012,237,540 | 21 / 19 |
| 2026-07-31 | $4.67 | $7,919,941,080 | 13 / 14 |
| 2026-08-01 | $4.67 | $7,919,941,080 | 13 / 14 |
| 2026-08-02 | $4.67 | $7,910,029,710 | 21 / 19 |
| 2026-08-03 | $4.67 | $7,910,029,710 | 21 / 19 |
| 2026-08-04 | $4.65 | $7,888,962,836 | 13 / 14 |
| 2026-08-05 | $4.66 | $7,879,596,640 | 21 / 19 |
| 2026-08-06 | $4.66 | $7,879,596,640 | 21 / 19 |
| 2026-08-07 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-08 | $4.67 | $7,879,596,640 | 21 / 19 |
| 2026-08-09 | $4.67 | $7,879,596,640 | 21 / 19 |
| 2026-08-10 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-12 | $4.67 | $7,879,596,640 | 21 / 19 |
| 2026-08-13 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-14 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-15 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-16 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-17 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-18 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-19 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-20 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-21 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-22 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-23 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-24 | $4.66 | $7,873,672,723 | 13 / 14 |
| 2026-08-25 | $4.66 | $7,876,479,422 | 13 / 14 |
| 2026-08-26 | $4.66 | $7,876,479,422 | 13 / 14 |
| 2026-08-27 | $4.66 | $7,876,479,422 | 13 / 14 |
| 2026-08-28 | $4.66 | $7,876,479,422 | 13 / 14 |
| 2026-08-29 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-08-30 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-08-31 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-09-01 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-09-02 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-09-03 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-09-04 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-09-05 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-09-06 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-09-07 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-09-08 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-09-09 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-09-10 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-09-11 | $4.66 | $7,876,479,422 | 14 / 14 |
| 2026-09-12 | $4.65 | $7,876,462,496 | 14 / 14 |
| 2026-09-13 | $4.65 | $7,876,462,496 | 14 / 14 |
| 2026-09-14 | $4.65 | $7,876,462,496 | 14 / 14 |
| 2026-09-15 | $4.65 | $7,876,462,496 | 14 / 14 |
| 2026-09-16 | $4.65 | $7,876,462,496 | 14 / 14 |
| 2026-09-17 | $4.65 | $7,876,462,496 | 14 / 14 |
| 2026-09-18 | $4.65 | $7,876,462,496 | 14 / 14 |
| 2026-09-19 | $4.65 | $7,876,462,496 | 14 / 14 |
| 2026-09-20 | $4.65 | $7,876,479,422 | 14 / 14 |
| 2026-09-21 | $4.65 | $7,876,479,422 | 14 / 14 |
| 2026-09-22 | $4.65 | $7,876,479,422 | 14 / 14 |
| 2026-09-23 | $4.65 | $7,876,479,422 | 14 / 14 |
| 2026-09-24 | $4.65 | $7,876,479,422 | 14 / 14 |
| 2026-09-25 | $4.65 | $7,876,479,422 | 14 / 14 |
| 2026-09-26 | $4.65 | $7,876,584,685 | 14 / 14 |
| 2026-09-27 | $4.65 | $7,876,584,685 | 14 / 14 |
| 2026-09-28 | $4.65 | $7,876,584,685 | 14 / 14 |
| 2026-09-29 | $4.65 | $7,876,584,685 | 14 / 14 |
| 2026-09-30 | $4.65 | $7,876,584,685 | 14 / 14 |
| 2026-10-01 | $4.65 | $7,876,584,685 | 14 / 14 |
| 2026-10-02 | $4.65 | $7,876,584,685 | 14 / 14 |
| 2026-10-03 | $4.65 | $7,876,584,685 | 14 / 14 |
| 2026-10-04 | $4.65 | $7,876,584,685 | 14 / 14 |
| 2026-10-05 | $4.65 | $7,876,584,685 | 14 / 14 |
| 2026-10-06 | $4.65 | $7,876,584,685 | 14 / 14 |
| 2026-10-07 | $4.64 | $7,874,540,451 | 14 / 15 |
| 2026-10-08 | $4.64 | $7,865,900,451 | 14 / 15 |
| 2026-10-09 | $4.63 | $7,862,029,491 | 14 / 16 |
| 2026-10-10 | $4.63 | $7,862,029,491 | 14 / 16 |
| 2026-10-11 | $4.63 | $7,862,029,491 | 14 / 16 |
| 2026-10-12 | $4.63 | $7,862,029,491 | 14 / 16 |
| 2026-10-13 | $4.61 | $7,850,472,781 | 14 / 16 |
| 2026-10-14 | $4.61 | $7,850,722,781 | 14 / 16 |
| 2026-10-15 | $4.61 | $7,849,953,554 | 14 / 16 |
| 2026-10-16 | $4.60 | $7,844,613,554 | 14 / 16 |
| 2026-10-17 | $4.60 | $7,844,613,554 | 14 / 16 |
| 2026-10-18 | $4.60 | $7,838,847,474 | 14 / 16 |
| 2026-10-19 | $4.60 | $7,838,847,474 | 14 / 16 |
| 2026-10-20 | $4.60 | $7,838,847,474 | 14 / 16 |
| 2026-10-21 | $4.60 | $7,838,847,474 | 14 / 16 |
| 2026-10-22 | $4.59 | $7,833,347,474 | 14 / 16 |
| 2026-10-23 | $4.59 | $7,833,347,474 | 14 / 16 |
| 2026-10-24 | $4.59 | $7,833,347,474 | 14 / 16 |
| 2026-10-25 | $4.59 | $7,833,347,474 | 14 / 16 |
| 2026-10-26 | $4.59 | $7,833,347,474 | 14 / 16 |
| 2026-10-27 | $4.59 | $7,833,347,474 | 14 / 16 |
| 2026-10-28 | $4.59 | $7,833,347,474 | 14 / 16 |
| 2026-10-29 | $4.69 | $7,874,140,546 | 14 / 16 |
| 2026-10-30 | $4.69 | $7,868,928,369 | 14 / 15 |
| 2026-10-31 | $4.69 | $7,868,928,369 | 14 / 16 |
| 2026-11-01 | $4.69 | $7,868,928,369 | 14 / 16 |
| 2026-11-02 | $4.69 | $7,868,928,369 | 14 / 16 |
| 2026-11-03 | $4.70 | $7,867,778,369 | 14 / 16 |
| 2026-11-04 | $4.70 | $7,867,778,369 | 14 / 16 |
| 2026-11-05 | $4.70 | $7,867,778,369 | 14 / 16 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 6 Buy / Strong Buy · 15 Hold · 1 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 9 recorded
1 raises · 1 cuts · 0 unchanged · 2 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.